| Dr Chad Ellis Nicholson, OD | |
|
6290 S Main St, Suite 100, Aurora, CO 80016-5322 | |
| (303) 766-0545 | |
| (303) 766-0624 |
| Full Name | Dr Chad Ellis Nicholson |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 24 Years |
| Location | 6290 S Main St, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366487829 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2131 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Altitude Eye Care | 2365778065 | 6 |
| Altitude Eye Care At Castlerock Pllc | 4688092711 | 3 |
| Southlands Vision Associates | 6709880792 | 3 |
News Archive
Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets.
Perinatal mood episodes are highly prevalent in women with bipolar disorder and recurrent major depression, UK research shows.
Novo Nordisk today announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A.
"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% of the patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
› Verified 5 days ago
| Provider Name | Southlands Vision Associates |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184645178 PECOS PAC ID: 6709880792 Enrollment ID: O20060906000080 |
News Archive
Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets.
Perinatal mood episodes are highly prevalent in women with bipolar disorder and recurrent major depression, UK research shows.
Novo Nordisk today announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A.
"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% of the patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
› Verified 5 days ago
| Provider Name | Altitude Eye Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235797796 PECOS PAC ID: 2365778065 Enrollment ID: O20190801001053 |
News Archive
Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets.
Perinatal mood episodes are highly prevalent in women with bipolar disorder and recurrent major depression, UK research shows.
Novo Nordisk today announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A.
"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% of the patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
› Verified 5 days ago
| Provider Name | Altitude Eye Care At Castlerock Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679187850 PECOS PAC ID: 4688092711 Enrollment ID: O20200922000850 |
News Archive
Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets.
Perinatal mood episodes are highly prevalent in women with bipolar disorder and recurrent major depression, UK research shows.
Novo Nordisk today announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A.
"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% of the patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chad Ellis Nicholson, OD 6290 S Main St, Ste 100, Aurora, CO 80016-5379 Ph: (303) 766-0545 | Dr Chad Ellis Nicholson, OD 6290 S Main St, Suite 100, Aurora, CO 80016-5322 Ph: (303) 766-0545 |
News Archive
Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets.
Perinatal mood episodes are highly prevalent in women with bipolar disorder and recurrent major depression, UK research shows.
Novo Nordisk today announced the company will launch Novoeight (Antihemophilic Factor [Recombinant]) in the United States for people living with hemophilia A.
"Health insurer shares rose on Tuesday, while hospital stocks fell as investors anticipated a Republican victory in the special Massachusetts election for a new U.S. senator that would throw healthcare reform into uncertainty," Reuters reports. "The Street prefers a simple narrative," said Les Funtleyder, a health care analyst with Miller Tabak. "The narrative is Coakley in Massachusetts is in trouble and therefore the healthcare reform bill is also in trouble" (Krauskopf, 1/19).
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the February 3, 2011 issue of the American Journal of Clinical Oncology, Dipetrillo, et al., which demonstrate that 38% of the patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
› Verified 5 days ago
Brian Richard Williams, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 13955 E Mississippi Ave, Aurora, CO 80012 Phone: 303-695-4999 | |
Dr. John Peter Blink Ii, OD Optometrist Medicare: Medicare Enrolled Practice Location: 13955 E Mississippi Ave, Aurora, CO 80012 Phone: 303-696-4999 | |
Adventure Dental Vision And Orthodontics Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9333 E Colfax Ave, Aurora, CO 80010 Phone: 720-697-5332 Fax: 720-257-5337 | |
Elizabeth Helen Kaye, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 23473 E Moraine Pl, Aurora, CO 80016 Phone: 720-810-3926 | |
Developmental Pathways, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14280 E Jewell Ave Ste A, Aurora, CO 80012 Phone: 303-360-6600 Fax: 303-341-0382 | |
Thompson Sowash, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 13955 E Mississippi, Aurora, CO 80012 Phone: 303-695-4999 Fax: 303-695-0896 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 24101 E Orchard Rd Unit D, Aurora, CO 80016 Phone: 303-600-9087 |